News
DBT supported efficacy trial with recombinant BCG vaccine completes enrolment of 6000 health-workers and high risk individuals
The objective of this trial is to evaluate the ability of VPM1002 in reducing infection incidence and severe disease outcomes of COVID-19 among high-risk persons
Department of Biotechnology supports production scale-up of test kits from Mylab
The scale-up of Mylab’s pathodetect production is extension of DBT’s early support to support inventions from India in the fight against Covid. Mylab has a manufacturing capacity of 2,00,000 RT-PCR and 50,000 RNA tests.
Indian Healthcare Angels Forum Launched
Some well- known investors and investment facilitators have launched the Indian Healthcare Angels (IHA) Forum to bring in aspiring Angels and Angel investors to look at investing in Indian healthcare startups with a much more commitment in midst of the Corona Pandemic.
